ProMED
@promed_mail
@ISID_org's ProMED is the oldest existing event-based surveillance network, reporting on infectious diseases using a One Health approach. 🦠
ID: 37011196
http://www.promedmail.org 01-05-2009 18:50:34
42,42K Tweet
27,27K Followers
176 Following
IJID Editorial: The WHO mpox public health emergency of international concern declaration: need for reprioritisation of global public health responses to combat the MPXV Clade I epidemic International Society for Infectious Diseases ijidonline.com/article/S1201-…
A new #IJID Editorial is out now in response to the World Health Organization (WHO)'s declaration of the #Mpox outbreak as a public health emergency of international concern. #ISID ow.ly/4ucV50T8MFM
“Will mpox become a global pandemic like COVID-19?” – Article out now from New Scientist with commentary from ISID’s President, Paul Tambyah, on the need for improved vaccine availability in West and Central Africa to control the spread of #Mpox. newscientist.com/article/244538…
20th #ICID2024 real opportunity to hear about the cutting edge of infection and AI International Society for Infectious Diseases
Is the #mpox emergency at risk of being minimized once the news cycle moves on? 😷 ISID's President, Professor Paul Tambyah, comments in the Financial Times Financial Times Read his letter to the editor here ✍️: ft.com/content/23f417… #InfectiousDisease #WHO #PublicHealth #ISID
Our webinar "Understanding Tuberculosis: Diagnosis, Management, and Global Impact" with Dr Nadia Atiya and Dr Sadia Shakoor is now available to watch on-demand on the #ISID Knowledge Exchange! bioMérieux ow.ly/GfBs50TfTtp
In an interview with New Scientist, #ISID President Paul Tambyah comments on a new mRNA #mpox vaccine. Benefits of mRNA vaccines is the speed and ease of manufacture – which will boost supplies and get vaccines to LMICs with the most need 💉 newscientist.com/article/244652…